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The COVID-19 pandemic has been a masterclass in the need for accurate, population-wide, 
frequently updated, and rapidly analysed digital data sources in global health.  
 
This issue of Thorax presents two studies using data from the smartphone Zoe COVID 
Symptom Study app, which has been collecting voluntarily self-reported information from 
consenting participants ≥18 years on COVID-19 in the UK since its launch in March 2020. As 
of 16th December 2020, 4,481,148 individuals had registered to use the app across the UK, 
USA and Sweden.[1] While there are other citizen science studies running in the UK to track 
COVID-19 symptoms (e.g. FluSurvey / Influenzanet and TrackTogether), the Zoe COVID 
app is by far the most extensive of these in coverage and participation numbers, and has 
contributed e.g. to identification of anosmia as a key symptom of COVID-19 in general (in 
May 2020),[2] and delirium as a key symptom in older people (October 2020).[3] 
 
In this issue, Hopkinson et al. sought to examine the impact of current smoking on the 
development of COVID-19, using data from March to April 2020.[4] Among individuals who 
did not think they had previously had COVID-19, self-declared current smokers reported 
slightly increased odds for presenting the classic triad (cough, fever, breathlessness) of 
symptoms than non-smokers (odds ratio 1.14 [95% confidence interval 1.10-1.18]), in results 
adjusted for age, sex and body mass index (BMI). This association did not hold when 
analyses were constricted to individuals tested for SARS-CoV-2 (0.73 [0.65-0.81]), including 
after adjustment for potential confounding due to being a healthcare worker (such individuals 
were early targets of testing and had a lower prevalence of smoking). (Of note, collider bias 
due to selected sampling has been reported as a potential cause of apparent ‘protective’ 
effects of smoking in early COVID-19 studies.[5]) Smokers who tested positive did, however, 
report more than double the odds of being hospitalised due to their COVID-19 (2.11 [1.41-
3.11]), an association which remained when individuals who reported comorbidities were 
removed from the analysis, or the model was adjusted for healthcare worker status. 
Although establishment of an association between being a current smoker and COVID-19 
disease remains uncertain within this study, the association with hospitalisation is 
concerning and deserves further exploration in models adjusting for socioeconomic status, 
ethnicity, and other confounding factors. Notably, a series of systematic reviews published in 
recent months have demonstrated an association between smoking and mortality as well as 
disease severity e.g. Dorjee et al.[6]  
 
Bowyer et al. investigated the geographical distribution of COVID-19 and its association with 
deprived areas, using self-reported data from March to April 2020 across the UK.[7] Higher 
predicted COVID-19 incidence was observed in urban and more deprived areas compared 
to rural and less deprived areas respectively, adjusted by air pollution, primary care centres 
per area, household density, urbanicity, age, sex and spatial autocorrelations. This 
association is in line with other studies e.g. from the US.[8] People living in deprived areas 
are more likely to have unstable and short-term employment that cannot facilitate home-
based remote working, and issues taking sick leave. Further instability has been added into 
the job market due to the economic downturn. Additionally, people living in deprived areas 
are more likely to live in high geographical density higher-occupancy housing, and have 
greater prevalence of key comorbidities. These factors are relevant for initial COVID-19 
disease, and many will also be pertinent for the impact of long COVID. The role of 
deprivation in the pandemic speaks to the general need for government policies to reduce 
inequalities, as well as holistic planning across different sectors for future pandemics- all 
government departments should be committed to pandemic preparedness, not simply those 
for healthcare and public health. 
 
As the above studies demonstrate, citizen science- the active and voluntary participation of 
the public in research; typically collecting data that are impractical to record otherwise, often 
over short timescales or large geographical areas- has been invaluable in the pandemic. In 
the context of the Zoe app, it has not only allowed the monitoring of the spread of COVID-19 
across the UK when access to testing was limited and slow (and people were perhaps not 
aware their symptoms might be relevant), but also to answer particular research questions. 
Even with the recognised limitations in app-collected and self-reported data, a wider picture 
of likely infection levels was provided than was otherwise possible.[9] The Zoe COVID app 
data has broadly agreed with the government’s ranking of most affected areas, confirming 
the validity of the approach, and providing especial benefit in places with limited routine 
testing. Additionally, depending on country- and community-specific factors, citizen science 
projects undertaken by independent institutions can be met with greater public trust that data 
collection by the government. In either respect, trust between data provider and data 
collector is paramount, including on issues of data protection and ownership 
 
Tracking disease spread is an increasingly common usage for citizen science within 
ecological fields,[10] and similar principles apply for COVID-19, where effective responses 
have hinged on knowing where it is and how fast it is spreading, as quickly as possible. 
Citizen science studies within the pandemic have been greatly enhanced by smartphones 
and the availability of the internet, allowing for broad and fast information capture and active 
reporting back to participants. Biological testing requires distribution, application and 
processing, whereas self-reporting of symptoms takes a few minutes. 
 
Citizen science comes with recognised biases. App users are not representative of the 
general population, generally showing clear differences in age, gender, educational level 
and income. The subject area of a voluntary study tends to attract people with pre-existing 
reasons to be interested in that field: more health-conscious groups in this case; and other 
areas of collider biases. It is possible to compensate for some of these biases in analysis, 
but results must be interpreted with this in mind, and the implications of a lack of 
generalisability and poor statistical certainty in poorly represented groups be kept at the 
forefront of all policy and resource-prioritisation decisions so as to avoid further exacerbating 
pre-existing inequalities. 
 
Like nothing before in human history, the COVID-19 pandemic has called for rapid, 
interdisciplinary, scientific studies and innovative methods of data collection, as 
professionals worldwide have worked to contain the virus. Within this, voluntary citizen 
engagement has been critical for effective pandemic responses, both in terms of 
engagement with rules and regulations, and understanding how responsiveness has been 
limited by the speed of possible scientific progress. Citizen science has been a key element 
in our engagement toolbox and provides a template for future work in global health. Moving 
forwards, it is critical that the expertise gained during this pandemic is not lost e.g. the need 
for hibernated projects that can be rapidly activated to provide data to support public health 
surveillance and research questions when a potential pandemic is first detected. 
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